Document Detail


Predispensing of antivirals to high-risk individuals in an influenza pandemic.
MedLine Citation:
PMID:  20029604     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
We consider the net benefits of predispensing antivirals to high-risk individuals during an influenza pandemic, where the measure of the benefit is the number of severe outcomes (such as deaths or hospitalizations) prevented by antivirals in the whole population. One potential benefit of predispensing is that individuals to whom antivirals have been predispensed may be able to initiate treatment earlier than if they had to wait to obtain and fill a prescription, reducing their risk of progression to severe disease. If this benefit exceeds the side effects of misuse for the category of individuals to whom antivirals were predispensed, and if antiviral supply exceeds overall population demand (which appears relevant for several countries including US in the current H1N1 pandemic), predispensing a quantity of antivirals not exceeding the difference between supply and demand is always beneficial. In this paper we consider the net benefits of predispensing antivirals under various scenarios, including demand exceeding supply, and derive mathematical conditions under which antiviral predispensing is advantageous on balance. For individuals whose relative risk of severe outcome is high enough, such as immunosuppressed individuals (particularly children) and possibly individuals with neurological disorders, predispensing is always beneficial at a given level of antiviral stockpile with modest assumptions on the relative benefit of early treatment by a predispensed course, regardless of the overall population demand for antivirals during the course of an epidemic. Making additional assumptions on either the overall population demand for antivirals (which appear relevant in the current situation) or on the relative benefit of predispensing would make predispensing net beneficial with inclusion of a larger number of persons such as pregnant women and morbidly obese adults.
Authors:
Edward Goldstein; Joel C Miller; Justin O'Hagan; Marc Lipsitch
Related Documents :
19011914 - Hybrid risk adjustment for pharmaceutical benefits.
22434004 - Transboundary movement of shrimp viruses in crustaceans and their products: a special r...
24335784 - Intervening to prevent repeat offending among moderate- to high-risk domestic violence ...
23600544 - Prenatal smoke exposure, dna methylation, and childhood atopic dermatitis.
11000714 - Maternal and fetal characteristics in an obstetric cohort in mozambique.
18949734 - Early detection of patients at high risk for acute kidney injury during disasters: deve...
Publication Detail:
Type:  Duplicate Publication; Journal Article     Date:  2009-08-21
Journal Detail:
Title:  PLoS currents     Volume:  1     ISSN:  2157-3999     ISO Abbreviation:  PLoS Curr     Publication Date:  2009  
Date Detail:
Created Date:  2009-12-23     Completed Date:  2010-02-12     Revised Date:  2013-03-11    
Medline Journal Info:
Nlm Unique ID:  101515638     Medline TA:  PLoS Curr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  RRN1007     Citation Subset:  -    
Affiliation:
Harvard School of Public Health, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
U54 GM088558-01/GM/NIGMS NIH HHS
Comments/Corrections
Update In:
Influenza Other Respi Viruses. 2010 Mar;4(2):101-12   [PMID:  20167050 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trajectory and velocity measurement of a particle in spray by digital holography.
Next Document:  The Contribution of the PB1-F2 protein to the fitness of Influenza A viruses and its recent evolutio...